5.99
Galectin Therapeutics Inc stock is traded at $5.99, with a volume of 74,696.
It is up +5.29% in the last 24 hours and up +37.88% over the past month.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
See More
Previous Close:
$5.67
Open:
$5.7
24h Volume:
74,696
Relative Volume:
0.24
Market Cap:
$383.72M
Revenue:
-
Net Income/Loss:
$-45.08M
P/E Ratio:
-8.2055
EPS:
-0.73
Net Cash Flow:
$-33.68M
1W Performance:
+16.83%
1M Performance:
+37.88%
6M Performance:
+355.73%
1Y Performance:
+129.17%
Galectin Therapeutics Inc Stock (GALT) Company Profile
Name
Galectin Therapeutics Inc
Sector
Industry
Phone
678-620-3186
Address
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Compare GALT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
GALT
Galectin Therapeutics Inc
|
5.99 | 365.60M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.62 | 107.10B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
630.39 | 66.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.66 | 55.95B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
827.14 | 51.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.46 | 38.98B | 447.02M | -1.18B | -906.14M | -6.1812 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-17-25 | Resumed | H.C. Wainwright | Buy |
| Aug-13-20 | Reiterated | H.C. Wainwright | Buy |
| Feb-13-19 | Initiated | B. Riley FBR | Buy |
| Dec-07-17 | Reiterated | H.C. Wainwright | Buy |
| Nov-28-17 | Reiterated | H.C. Wainwright | Buy |
| Oct-19-17 | Initiated | ROTH Capital | Buy |
| Mar-30-17 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Oct-03-16 | Downgrade | FBR & Co. | Outperform → Mkt Perform |
| Sep-29-16 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-28-16 | Downgrade | ROTH Capital | Buy → Sell |
| Mar-28-16 | Resumed | H.C. Wainwright | Buy |
| Sep-21-15 | Initiated | H.C. Wainwright | Buy |
| Aug-01-14 | Downgrade | Aegis Capital | Buy → Hold |
| Jul-30-14 | Reiterated | MLV & Co | Buy |
| Jul-29-14 | Reiterated | MLV & Co | Buy |
| Apr-02-14 | Reiterated | MLV & Co | Buy |
| Feb-10-14 | Reiterated | Aegis Capital | Buy |
| Jan-09-14 | Reiterated | Aegis Capital | Buy |
| Dec-03-13 | Initiated | MLV & Co | Buy |
| Aug-19-13 | Reiterated | Aegis Capital | Buy |
View All
Galectin Therapeutics Inc Stock (GALT) Latest News
Can you recover from losses in Galectin Therapeutics Inc.2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - newser.com
Applying Elliott Wave Theory to Galectin Therapeutics Inc.2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Is Galectin Therapeutics Inc. (PHPN) stock among top earnings plays2025 Analyst Calls & Weekly High Return Forecasts - newser.com
What sentiment indicators say about Galectin Therapeutics Inc. stock2025 Sector Review & Community Consensus Trade Alerts - newser.com
Galectin Therapeutics (NASDAQ:GALT) Stock Passes Above 200-Day Moving AverageTime to Sell? - MarketBeat
What valuation multiples suggest for Galectin Therapeutics Inc. stock2025 Price Targets & Entry Point Confirmation Alerts - newser.com
What is the fair value estimate for Galectin Therapeutics Inc. (PHPN) stock in 2025Day Trade & Community Consensus Trade Alerts - newser.com
Can Galectin Therapeutics Inc. (PHPN) stock sustain margin levelsGDP Growth & Daily Entry Point Trade Alerts - newser.com
Is Galectin Therapeutics Inc. forming a reversal patternTrade Risk Summary & Community Trade Idea Sharing - newser.com
Identifying reversal signals in Galectin Therapeutics Inc.Options Play & Free Growth Oriented Trading Recommendations - newser.com
Is Galectin Therapeutics Inc. (PHPN) stock cheap by valuation metrics2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
Will Galectin Therapeutics Inc. (PHPN) stock beat growth indexesJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com
Will Galectin Therapeutics Inc. stock benefit from green energy trends2025 Fundamental Recap & Long-Term Investment Growth Plans - fcp.pa.gov.br
Why Galectin Therapeutics Inc. (PHPN) stock could rally stronglyJuly 2025 Big Picture & Free Weekly Chart Analysis and Trade Guides - Fundação Cultural do Pará
Galectin Therapeutics Inc. (GALT) Stock forecasts - Yahoo! Finance UK
Galectin Therapeutics Inc Stock (GALT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Galectin Therapeutics Inc Stock (GALT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| CALLICUTT JACK W | Chief Financial Officer |
Sep 12 '25 |
Option Exercise |
1.37 |
8,706 |
11,927 |
16,320 |
| CALLICUTT JACK W | Chief Financial Officer |
Sep 12 '25 |
Sale |
6.44 |
8,706 |
56,054 |
7,614 |
| LEWIS JOEL | President and CEO |
Sep 12 '25 |
Option Exercise |
2.39 |
14,000 |
33,460 |
846,592 |
| LEWIS JOEL | President and CEO |
Sep 12 '25 |
Sale |
6.36 |
14,000 |
89,048 |
832,592 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):